Publications found:
253,269
Sort by:
Digital Health Quarterly 4Q 2011 1Q 2012
US$ 1,500.00
The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.
December 2011
17 pages
Health Entertainment: Bringing the Fun to Wellness and Fitness 3Q 2012
US$ 3,500.00
This report analyzes the intersection of the entertainment world with human health and well being. It defines this unique industry sector with ... -user revenues. "Health entertainment is a perfect example of technology’s imprint on the science of human behavioral changes," said Harry Wang, Director of Mobile & Health Research at Parks ...
December 2011
55 pages
Global Pharmaceutical & Biotechnology Outlook 2012
US$ 12,000.00
... strategic and long term investment decision making of senior management. Outlook-11’ has been tailored to deliver more meaningfully in the ... for the future, and their key milestones. The Global Pharmaceutical Model is changing. Major pharmaceutical companies continue to under-perform in a market constrained ...
December 2011
466 pages
Para IV pluse Subscriptions
US$ 4,500.00
Para IV Plus is a knowledge bank of ongoing pharma patent litigations covered in the most comprehensive manner. Currently it covers ~400 product patent litigations – i.e. ALL the patent litigations involving global as well as non global innovator companies.
December 2011
Point of Care Diagnostics: World Market Outlook 2012-2021
US$ 2,635.00
... interview (shown in the accompanying lists). Why you should buy Point of Care Diagnostics: World Market Outlook 2012-2021 In this report, you will ... assess leading manufacturers and products in the leading segments of the point of care diagnostics market, with information on the pipeline products You will ...
December 2011
126 pages
Global In Vitro Diagnostic Market Analysis
US$ 1,600.00
With the rapidly diversifying diagnostic industry, the In Vitro Diagnostic (IVD) has evolved as a major contributing segment. Extensive scientific research and development, technological advancements,...
December 2011
130 pages
US Biotech Market Analysis
US$ 1,000.00
The US represents the world’s largest biotechnology market, leading with its innovation, extensive R&D, and regular company developments in various spheres of the biotechnology sector. On the back...
December 2011
65 pages
Global HIV Therapeutics Market Analysis
US$ 1,200.00
HIV endemic has had devastating economic, social, health and psychological impacts over the years affecting millions of households in a significant manner over the last decade. Despite the concrete ef...
December 2011
70 pages
Global Regenerative Medicine Market
US$ 1,200.00
Regenerative medicine is an emerging interdisciplinary field that spans tissue engineering, stem-cell biology, nanoscience, and bioengineering for the repair of cells, tissues and organs. It seeks to...
December 2011
105 pages
US Healthcare Market Outlook 2013
US$ 1,000.00
The US represents the world’s largest healthcare market, with a high annual healthcare spending. The growth in healthcare spending is mainly driven by high administrative costs, and expensive hospital...
December 2011
80 pages
Future Cancer Diagnostic Technologies and Market Applications
US$ 1,480.00
... , immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. Contains 110 pages
December 2011
110 pages
Emerging Coagulation Tests and Suppliers Developing New Technologies
US$ 1,480.00
The report presents an overview of the clinical significance and market needs for major coagulation laboratory tests, as well as extensive listings of companies developing or marketing new coagulation technologies and products. Contains 125 pages and 20 tables
December 2011
125 pages
Emerging Cancer Molecular Diagnostic Tests
US$ 1,160.00
The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing molecular diagnostic technologies and products for cancer testing. Contains 45 pages and 1 table
December 2011
45 pages
Kraft Foods inc in Health and Wellness (World)
US$ 572.00
... the wake of the Cadbury acquisition, Kraft Foods nearly doubled its global health and wellness (HW) sales to US$16.5 billion in ... its portfolio development with key wellness trends. Euromonitor International’s Kraft Foods Inc in Health and Wellness (World) Company Profile offers detailed strategic ...
December 2011
49 pages
European Markets for Orthopedic Large Joint Reconstructive Devices 2011
US$ 11,495.00
In 2010, the combined European large joint orthopedic reconstruction device market was valued at over €1.9 billion. The countries covered in this report include ... include: The knee reconstruction market The hip reconstruction market The bone cement market Within the orthopedic large joint replacement and ...
December 2011
316 pages
Outlook 2012 - Rising Stars - Innovators Deliver but Rewards Not Guranteed!
US$ 2,000.00
... continue to flow from the backyards of small research focused companies (Rising stars, RS) but commercial success of launched products is not assured despite patents ... Micromet (MITI) are our Top Picks for FY2012 in the Rising Stars Sector. Key drugs of ANTH and MITI target high unmet ...
December 2011
52 pages
Competitor Analysis: HIV Small Molecule Therapeutics
US$ 642.00
The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides a competitor evaluation in the field of marketed...
December 2011
100 pages
Outlook 2012 - Mature Biotech - Investing in Growth and Value buys!
US$ 2,000.00
... ’ in 2011! We expect a similar trend of acquisitions and in-licensing of better molecules in 2012 and beyond, as MB companies have robust cash flow to further leverage ... Gilead (GILD) are our Top Picks for FY2012 in the Mature Biotech Sector. BIIB’s focus and leadership in the MS market and positive ...
December 2011
46 pages
Outlook 2012 - Japanese Pharma - Cautious Ideas to Seize Value in Happening 2012!
US$ 2,000.00
‘Japanese Pharma Top & Bottom Picks’. Our analysis suggests that 2012 is going to be a happening year for Japan Pharma on multiple fronts – while next layer of reform ... largely supporting generic companies, select innovators from Japan hold value in term of their R&D. 2012 will unfold much of this value and ...
December 2011
78 pages
NOVARTIS - Tekturna: ALTITUDE study in high risk hypertensive patients TERMINATED
US$ 90.00
... the termination of large PhIII study (ALTITUDE) due to higher rate of adverse events and no benefits observed for patients taking Tekturna in addition to ACE ... inhibitors. Post this announcement, NVS will cease promotion of Tekturna/Tekturna products in combination with ACE inhibitors/ARB inhibitors. The event ...
December 2011
1 pages
LUPIN - Lupin - Loss of 2 Exclusivities Further Exposes the weak Pipeline
US$ 140.00
... . Most glaring is the Fortmet case, where Lupin launched the product ‘at-risk’ and later withdrew ... settled with Lupin it cannot launch its generic version (unless ‘at-risk’) thereby leading to a loss of this ... shared 180-day exclusivity for Lupin. These add to the pressure ...
December 2011
3 pages
Cardiac Rhythm Management Devices: World Market Outlook 2011-2021
US$ 2,635.00
... decisions. The market will change with the launch of new products such as devices suitable for use with MRI and biological pacemakers. Find R&D trends ... (shown in the accompanying lists). Why you should buy Cardiac Rhythm Management Devices: World Market Outlook 2011-2021 In this report, you will receive ...
December 2011
145 pages
MSL-KOL Engagement: Measuring Success
US$ 595.00
It’s difficult to quantify. Its role constantly changes. And despite all efforts to gain transparency, the field of medical science liaison (MSL) remains an elusive—seemingly immeasurable—yet undeniab...
November 2011
26 pages
Assessment of the fast growing Indian Biotech Market
US$ 800.00
... The country is a favored destination in custom research outsourcing and custom manufacturing outsourcing (CMO). Growth in the sector is likely to come from India's strong position in biosimilars, molecular diagnostics and personalized medicine. However, the industry is also facing various challenges such as ...
November 2011
30 pages
Vertex – “Testing Time Ahead for INCIVEK - After 2013!”
US$ 140.00
... in 2014, would result in declining sales for INCIVEK/IFN combination. Vertex (VRTX) next target is to capture the HCV/HIV co-infected patients ... read our report released on 25th November, 2011 on VRTX titled “Testing Time Ahead for INCIVEK - After 2013!”
November 2011
10 pages
Generic Drug Market in Canada
US$ 1,000.00
Canada is one of the world’s largest pharmaceutical markets, even though it has a low share of only 3% in global pharma industry. In 2010, generics accounted for more than 57% prescriptions and around...
November 2011
65 pages
US Glucose Monitoring Market Analysis
US$ 1,000.00
The US has a dominant share in the global diabetes market with 90-95% of the diabetic patients in the country suffering from type-II diabetes. Factors like, high prevalence of diabetes, rising aging p...
November 2011
55 pages
Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems
US$ 3,500.00
... are among the factors driving these imaging markets. This report, Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems from ... based systems to filmless environments. At the same time there are practical limiters to digital and areas where film-based systems will still be useful, ...
November 2011
150 pages
World Market for Medical Beds
US$ 2,995.00
... Including: Acute Long Term Home Care Regional Medical Bed Markets: US Europe Asia Rest of World There are several primary issues and ... Purchases Increasing Incidence of Disease Results of Recent Acquisitions Healthcare Reform Bed Safety and Safety Rail Issues Insurance and Reimbursement The ...
November 2011
150 pages
World Market for Prescription Arthritis Treatments
US$ 3,500.00
... management. This Kalorama Information report, The World Market for Prescription Arthritis Treatments, details the market for these treatments. The report provides ... There are several issues and trends that are shaping this market. Some of the topics, discussed in this report include: US Economic Impact ...
November 2011
150 pages
U.S. Market for Arthroscopic Devices 2011
US$ 7,495.00
... was resurgence in procedures due tothe accumulated demand which drove arthroscopic device market growth. Within the soft tissue and sports medicine market, ... , ConMed Linvatec, DePuy Mitek, Smith & Nephew and Stryker lead the market, among many others. This report provides a comprehensive and detailed analysis ...
November 2011
European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive)
US$ 11,495.00
... replacing the natural lens when it has been damaged by cataracts. The market segments covered in this report include: Optical Coherence Tomographers Fundus ... Scandinavia Spain Switzerland The United Kingdom Within the European Ophthalmic device market, companies such as Alcon, AMO, Bausch & Lomb, Carl ...
November 2011
European Markets for Women’s Health Devices 2011
US$ 11,495.00
... 2010, the market for women’s health devices in Europe was valued at €667.6 million. The main conditions dealt with by women’s health professionals ... , and gynecologists move intourology and other surgery specialties. This European report covers: Austria, Benelux, France, Germany, Italy, Portugal, Spain ...
November 2011
Aloka in the Global Diagnostic Imaging Sector
US$ 1,520.00
A strategic assessment of Aloka, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's ...
November 2011
32 pages
Global Diagnostic Imaging Companies Financial Performance
US$ 1,960.00
Each company’s analysis provides: Sales estimates by division, geographic region, and modality. Five-year sales and operating profit performance. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 92 pages and 78 tables
November 2011
92 pages
Global Diagnostic Imaging Companies M&A, Business Organizations, and Senior Management
US$ 1,480.00
... , divestitures, and significant organizational changes. Current organizational structure. Management philosophy and attitudes toward the diagnostic imaging market. Background of key executives. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, ...
November 2011
92 pages
Global Diagnostic Imaging Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
US$ 10,000.00
... , factual, annually updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading diagnostic imaging companies. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-a-vis the leading competitors. ...
November 2011
850 pages